Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01917773 · ClinicalTrials.gov registry record · Phase 4
Effect of Octreotide on the Colonic Motility in Pediatric Patients
A Phase 4 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 4
- Development phase
- 13
- Enrollment target
NCT01917773 is a Phase 4 study that has completed, run by Indiana University. The registered enrollment target is 13 participants.
The verdict
NCT01917773, a Phase 4 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 13 participants
- Enrollment target
Study Summary
The research study is designed to test how a medication called octreotide affects the motility (contraction or squeezing) of the colon (large intestine). Investigators are investigating whether octreotide can increase contraction and movement in the colon.
Interventions
- DRUG Octreotide
- DRUG Bisacodyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01917773
The ClinicalTrials.gov registry entry for NCT01917773 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Octreotide is the first listed.
NCT01917773 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01917773 about?
NCT01917773 is a clinical study titled "Effect of Octreotide on the Colonic Motility in Pediatric Patients". The research study is designed to test how a medication called octreotide affects the motility (contraction or squeezing) of the colon (large intestine). Investigators are investigating whether octreotide can increase contraction and movement in the colon.
What is the current status of trial NCT01917773?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 13 participants. The study started on 2013-08. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01917773?
The interventions under investigation include: Octreotide (DRUG), Bisacodyl (DRUG).
Who is sponsoring clinical trial NCT01917773?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.